Fulcrum Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Fulcrum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fulcrum Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fulcrum Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $638k | 69k | 9.20 |
| 2025-06-30 | $573k | 83k | 6.88 |
| 2025-03-31 | $256k | 89k | 2.88 |
| 2024-12-31 | $416k | 89k | 4.70 |
| 2024-09-30 | $311k | 87k | 3.57 |
| 2024-06-30 | $567k | 91k | 6.20 |
| 2024-03-31 | $16k | 1.7k | 9.44 |
| 2023-12-31 | $11k | 1.7k | 6.75 |
| 2023-09-30 | $7.4k | 1.7k | 4.44 |
| 2023-06-30 | $16k | 4.8k | 3.30 |
| 2023-03-31 | $215k | 76k | 2.85 |
| 2022-12-31 | $435k | 60k | 7.28 |
| 2022-09-30 | $410k | 51k | 8.08 |
| 2022-06-30 | $233k | 48k | 4.90 |
| 2022-03-31 | $807k | 34k | 23.66 |
| 2021-12-31 | $561k | 32k | 17.69 |
| 2021-09-30 | $852k | 30k | 28.21 |
| 2021-06-30 | $236k | 23k | 10.50 |
| 2021-03-31 | $146k | 12k | 11.82 |
| 2020-12-31 | $139k | 12k | 11.72 |
| 2020-09-30 | $84k | 11k | 7.91 |
| 2020-06-30 | $233k | 13k | 18.31 |